Cargando…
An Evidence-Based Approach to the Use of Predictive Biomarkers in the Treatment of Non- Small Cell Lung Cancer (NSCLC)
Recent advances in the treatment of non-small cell lung cancer (NSCLC) have led to improvements in patient survival and quality of life. It is unclear whether molecular abnormalities associated with NSCLC cell survival, growth and proliferation are useful in predicting treatment benefit. We conducte...
Autores principales: | Quinton, Cindy, Ellis, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759208/ https://www.ncbi.nlm.nih.gov/pubmed/24212966 http://dx.doi.org/10.3390/cancers3033506 |
Ejemplares similares
-
The Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly: An Evidence-Based Approach
por: Dawe, David E., et al.
Publicado: (2014) -
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
por: Šutić, Maja, et al.
Publicado: (2021) -
MicroRNA‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)
por: Liao, Jipei, et al.
Publicado: (2020) -
Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)
por: Giustini, Nicholas, et al.
Publicado: (2021) -
Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
por: Guo, Shicheng, et al.
Publicado: (2015)